09:28 AM EDT, 05/06/2026 (MT Newswires) -- Taysha Gene Therapies (TSHA) reported a Q1 net loss Wednesday of $0.12 per diluted share, widening from a loss of $0.08 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.10.

The company didn't report revenue for the quarter ended March 31, compared with $2.3 million a year earlier.

Analysts surveyed by FactSet expected revenue of $800,000.

Shares of Taysha Gene Therapies were down 4% pre-bell.

Ämnen i artikeln

Taysha Gene Therapies

Senast

5,50

1 dag %

−6,62%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån